Dr. Thomas Michael Shimshak, MD

Dr. Shimshak practices at AdventHealth Sebring in Sebring, Florida, part of AdventHealth.

Dr. Shimshak's NPI, 1467567941, was assigned on August 21, 2006. Dr. Shimshak graduated from Medical College Of Wisconsin in 1980. Dr. Shimshak holds Florida license ME122398.

Dr. Shimshak's primary practice is AdventHealth Sebring, at 4200 Sun N Lake Blvd, Sebring, FL 33872 in Highlands County. The practice phone is (863) 314-4466.

Dr. Shimshak's primary practice is AdventHealth Sebring in Sebring, Florida, part of AdventHealth. Dr. Shimshak is also affiliated with BayCare Winter Haven Hospital. The medical group on file is AdventHealth Cancer Institute Sebring. Dmand AI also links Dr. Shimshak to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Shimshak practices, 4 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Shimshak's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Shimshak is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Shimshak's licenses on file in 4 states: Florida, Wisconsin, Pennsylvania and Ohio.

Dmand AI lists angioplasty, cardiac catheterization and leg revascularization among the conditions Dr. Shimshak treats.

CMS data shows 709 Medicare services from Dr. Shimshak across 13 procedure codes in 2024, for 255 Medicare patients. Medicare paid $93,635 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 255 Medicare patients who saw Dr. Shimshak in 2024. The largest group is 75 to 84, with 119 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.79, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Shimshak's median patient age at 76, with 39% women.

In 2024, Dr. Shimshak wrote 250 Medicare Part D claims for 101 patients. 88% of them were for generic drugs. CMS names the drug for 114 of them, across 1 drug with 11 or more claims each, at $979 in total drug cost. In 2023, CMS named 112 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Shimshak for performance year 2024, reported as part of a group. Dr. Shimshak accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 85 procedures of coronary angioplasty and stenting by Dr. Shimshak, more than 95% of the clinicians it reports for that procedure.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 48 papers to Dr. Shimshak, published from 2017 to 2024. 2023 was the busiest year, with 3. The most frequent topics are Angioplasty, Balloon, Coronary, Coronary Disease and Abciximab. Dr. Shimshak has published most often in Am J Cardiol. Dr. Shimshak's most frequent co-authors are Chad K. Brands, MD, Eric J. Dippel, MD and Malcolm Tennyson Foster, MD.

Dmand AI links Dr. Shimshak to 3 clinical trials. 1 is still active or recruiting. Conditions studied include Peripheral Arterial Disease and Peripheral Vascular Diseases.

CMS Open Payments shows 360 general payments to Dr. Shimshak from 31 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 79% of the total. Boston Scientific Corporation paid the most, $128,144.

Dmand AI lists 3 awards for Dr. Shimshak, most recently NCQA HSRP in 2017.

Dr. Shimshak graduated from Medical College Of Wisconsin in 1980.

Dr. Shimshak is in network with 18 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.